Fusen Pharmaceutical Company Limited (HKG:1652)
0.9300
+0.0400 (4.49%)
At close: Feb 13, 2026
132.50% (1Y)
| Market Cap | 687.55M +47.6% |
| Revenue (ttm) | 264.08M -43.4% |
| Net Income | -191.74M |
| EPS | -0.26 |
| Shares Out | 739.30M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,482,000 |
| Average Volume | 499,250 |
| Open | 0.8900 |
| Previous Close | 0.8900 |
| Day's Range | 0.8900 - 0.9700 |
| 52-Week Range | 0.2350 - 1.7500 |
| Beta | 0.13 |
| RSI | 78.77 |
| Earnings Date | Mar 27, 2026 |